Impact BioMedical Inc. (IBO) stock
IBONYSEPharmaceutical PreparationsFiscal year ends December 31
$3.06+0.38 (+14.18%)
Close on Oct 19, 2026Market cap $329.93MP/E –Yield –
Impact BioMedical gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Impact BioMedical's gross profit for the twelve months ending Dec 31, 2025 was -$392.00K. For fiscal 2025 it was -$392.00K.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$392.00K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.00K | – |
| Q4 FY2025 | Dec 31, 2025 | -$415.00K | – |
| Q3 FY2025 | Sep 30, 2025 | $17.00K | – |
| Q2 FY2025 | Jun 30, 2025 | $6.00K | – |
See a number that looks wrong?